Tag:
BioMarck Pharmaceuticals
Latest Headlines
Latest Headlines
BioMarck closes series C with over $6.3M
BioMarck Pharmaceuticals says it has closed its Series C round with over $6.3 million in financing. The Research Triangle Park, NC-based company raised most of the capital through existing investors.
